PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
November 13, 2023 16:03 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative...
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
November 01, 2023 16:02 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
October 16, 2023 16:05 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
October 12, 2023 08:00 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT), a surgical robotics global leader, is pleased to announce that the National Institute for Health...
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
September 20, 2023 08:00 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on developing transformative...
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
September 12, 2023 08:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today the...
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 22, 2023 08:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has...
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 17, 2023 16:05 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
August 16, 2023 08:00 ET
|
PROCEPT BioRobotics; NorthShore University HealthSystem
EVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics® announce a significant milestone in access to treatment of Benign Prostatic...
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
August 01, 2023 22:10 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by...